Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease

Hepatology

Volumn 27, Issue 6, 1998, Pages 1678-1686

  Brambilla, Sabrina ^a   Bellati, Giorgio ^b   Asti, Margherita ^a   Lisa, Antonella ^c   Candusso, Maria Elena ^a   D'Amico, Maria ^b   Grassi, Gabriele ^d   Giacca, Mauro ^d   Franchini, Angelo ^c   Bruno, Saving ^e   Ideo, Gaetano ^b   Mondelli, Mario U ^a   Silini, Enrico M ^a,f  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c CNR   (Italy)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^e Ospedale San Paolo   (Italy)

^f Istituto di Anatomia Patologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; EVOLUTION; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIVER BIOPSY; LIVER DISEASE; MALE; PRIORITY JOURNAL; VIRUS CARRIER; VIRUS GENE;

ADULT; AGED; CLONING, MOLECULAR; FEMALE; GENES, VIRAL; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

EID: 17344364102     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270629     Document Type: Article

References (28)

1. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Sem Liver Dis 1995;15:41-63.
2. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992;66:3225-3229.
3. Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, Ortin J, Lopez-Galindez C, et al. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations : biological releance - a review. Gene 1985;40:1-8.
4. Holland JJ, De la Torre JC, Steinhauer DA. RNA virus populations as quasispecies. Curr Topics Microbiol Immunol 1992;176:1-20.
5. Silini E, Mondelli MU. Significance of hepatitis C virus genotypes. Vir Hep Rev 1995;1:111-120.
6. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991;180:842-848.
7. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992;89:3468-3472.
8. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 1993;195:297-301.
9. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993;67:3923-3930.
10. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 1996;93:15394-15399.
11. Holmes EC, Zhang LQ, Simmonds P, Ludlam CA, Leigh Brown AJ. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A 1992;89:4835-4839.
12. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993;197:659-668.
13. Yamaguchi K, Tanaka E, Higashi K, Kiyosawa K, Matsumoto A, Furuta S, Hasegawa A, et al. Adaptation of hepatitis C virus for persistent infection in patients with acute hepatitis. Gastroenterology 1994;106:1344-1348.
14. Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 1994;68:4776-4784.
15. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991;88:2451-2455.
16. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. HEPATOLOGY 1994;20:1144-1151.
17. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-679.
18. Silini EM, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, et al. Differential distribution od hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995;21:285-290.
19. Grassi G, Pozzato G, Moretti M, Giacca M. Quantitative analysis of hepatitis C virus in liver biopsies by competitive reverse transcription and polymerase chain reaction. J Hepatol 1995;23:403-411.
20. Felsenstein J. Phylip manual, version 3.5c. University of Washington, Seattle 1990.
21. Nei M, Gojobori T. Simple methods for estimating the number of synonimous and nonsynonimous nucleotide substitutions. Mol Biol Evol 1986;3:418-426.
22. Jukes TH, Cantor CR. Evolution of protein molecules. In: Munro HN, ed. Mammalian Protein Metabolism. New York: Academic Press, 1969:121-132.
23. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-140.
24. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo Q-L, Houghton M, et al. HLA class-I restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995;96:2311-2321.
25. Rehermann B, Chang K-M, McHtchinson J, Kokka R, Houghton M, Rice CM, Chisari FV Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996;70:7092-7102.
26. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994;91:7792-7796.
27. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994;68:1494-1500.
28. Kanazawa Y, Hayashi N, Mita E, Li T, Hagiwara H, Kasahara A, Fusamoto H, et al. Influence of viral quasispecies on effectiveness of Interferon therapy in chronic hepatitis C patients. HEPATOLOGY 1994;20:1121-1130.